{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:44:20Z","timestamp":1765233860585,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T00:00:00Z","timestamp":1762041600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jtct.2024.08.011","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T07:22:53Z","timestamp":1724397773000},"page":"1102.e1-1102.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Retrospective Study of Pediatric Patients With Low- or Intermediate-Risk Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation for the AML-05 Study Conducted by the Japanese Pediatric Leukemia\/Lymphoma Study Group"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1668-274X","authenticated-orcid":false,"given":"Yoshiko","family":"Hashii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4612-4047","authenticated-orcid":false,"given":"Koji","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kurakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsutsugu","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiichiro","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Taki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Hyakuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8085-4940","authenticated-orcid":false,"given":"Masayuki","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6508-5496","authenticated-orcid":false,"given":"Hiromasa","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiro","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yozo","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Fujisaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimikazu","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Yanagimachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3783-2121","authenticated-orcid":false,"given":"Nao","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harumi","family":"Kakuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Satou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Tabuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1520-7007","authenticated-orcid":false,"given":"Daisuke","family":"Tomizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Taga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souichi","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyoshi","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7397-1575","authenticated-orcid":false,"given":"Koji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2024.08.011_bib0001","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jtct.2022.06.005","article-title":"Hematopoietic cell transplantation in the treatment of pediatric acute myelogenous leukemia and myelodysplastic syndromes: guidelines from the American Society of Transplantation and Cellular Therapy","volume":"28","author":"Tarlock","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2024.08.011_bib0002","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1200\/JCO.2011.41.5323","article-title":"Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia","volume":"30","author":"Inaba","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2024.08.011_bib0003","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41409-024-02197-3","article-title":"Cytogenetic abnormalities predict survival after allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a PDWP\/EBMT study","volume":"59","author":"Sharma","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.08.011_bib0004","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/ped.12865","article-title":"Acute myeloid leukemia in children: current status and future directions","volume":"58","author":"Taga","year":"2016","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jtct.2024.08.011_bib0005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/pbc.20944","article-title":"Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group","volume":"49","author":"Tomizawa","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2024.08.011_bib0006","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1200\/JCO.2008.18.7948","article-title":"Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group","volume":"27","author":"Tsukimoto","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2024.08.011_bib0007","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1038\/leu.2013.153","article-title":"Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in children","volume":"27","author":"Tomizawa","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2024.08.011_bib0008","doi-asserted-by":"crossref","first-page":"e28692","DOI":"10.1002\/pbc.28692","article-title":"Attempts to optimize postinduction treatment in childhood acute myeloid leukemia without core-binding factors: a report from the Japanese Pediatric Leukemia\/Lymphoma Study Group (JPLSG)","volume":"67","author":"Hasegawa","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2024.08.011_bib0009","doi-asserted-by":"crossref","first-page":"e27875","DOI":"10.1002\/pbc.27875","article-title":"Retrospective analysis of children with high-risk acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation following complete remission with initial induction chemotherapy in the AML-05 clinical trial","volume":"66","author":"Hyakuna","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2024.08.011_bib0010","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.08.011_bib0011","series-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"75","article-title":"Acute myeloid leukemia","author":"Brunning","year":"2001"},{"key":"10.1016\/j.jtct.2024.08.011_bib0012","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"110","article-title":"Acute Myeloid Leukemia","author":"Arber","year":"2008"},{"key":"10.1016\/j.jtct.2024.08.011_bib0013","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues WHO Classification of Tumours","first-page":"130","article-title":"Acute myeloid leukemia and related precursor peoplasmas","author":"Arber","year":"2017"},{"key":"10.1016\/j.jtct.2024.08.011_bib0014","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/bjh.14720","article-title":"Outcome after intensive reinduction therapy and allogeneic stem cell transplant in paediatric relapsed acute myeloid leukaemia","volume":"178","author":"Karlsson","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2024.08.011_bib0015","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.08.011_bib0016","first-page":"250","article-title":"Chronic graft-versus-host disease and other late complications of bone marrow transplantation","volume":"28","author":"Sullivan","year":"1991","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jtct.2024.08.011_bib0017","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1158\/1078-0432.CCR-20-4856","article-title":"Differential effect of graft-versus-host disease on survival in ccute leukemia according to donor Type","volume":"27","author":"Konuma","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtct.2024.08.011_bib0018","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.08.011_bib0019","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood.2019001212","article-title":"Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP\/CIBMTR","volume":"134","author":"Dehn","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.08.011_bib0020","series-title":"Pizzo and Poplack's Pediatric Oncology","first-page":"1393","article-title":"Acute myeloid leukemia and myelodysplastic syndromes","author":"Aplenc","year":"2021"},{"key":"10.1016\/j.jtct.2024.08.011_bib0021","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1182\/bloodadvances.2018025908","article-title":"The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia","volume":"3","author":"Keating","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2024.08.011_bib0022","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jcyt.2020.01.007","article-title":"Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes?","volume":"22","author":"Teofili","year":"2020","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jtct.2024.08.011_bib0023","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jtct.2021.09.013","article-title":"Guidelines for pediatric unrelated cord blood transplantation-unique considerations","volume":"27","author":"Dahlberg","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2024.08.011_bib0024","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1056\/NEJMoa1808777","article-title":"Immune escape of relapsed AML cells after allogeneic transplantation","volume":"379","author":"Christopher","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2024.08.011_bib0025","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1182\/blood-2018-99-112142","article-title":"Incidence of HLA loss in a global multicentric cohort of post-transplantation relapses: results from the Hlaloss Collaborative Study","volume":"132","author":"Vago","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.08.011_bib0026","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"Dohner","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.08.011_bib0027","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/bjh.13926","article-title":"Cord blood transplant for acute myeloid leukaemia","volume":"173","author":"Ballen","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2024.08.011_bib0028","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2022-159962","volume":"140","author":"Stelljes","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.08.011_bib0029","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/bjh.18039","article-title":"Clinical outcomes of second relapsed and refractory first relapsed paediatric AML: a retrospective study within the NOPHO-DB SHIP consortium","volume":"197","author":"White","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2024.08.011_bib0030","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1038\/sj.leu.2404681","article-title":"Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens","volume":"21","author":"Jim\u00e9nez","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2024.08.011_bib0031","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41588-023-01640-3","article-title":"A new genomic framework to categorize pediatric acute myeloid leukemia","volume":"56","author":"Umeda","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtct.2024.08.011_bib0032","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1470-2045(10)70090-5","article-title":"Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial","volume":"11","author":"Rubnitz","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtct.2024.08.011_bib0033","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12885-023-11784-4","article-title":"Prognostic significance of multiparametric flow cytometry minimal residual disease at two time points after induction in pediatric acute myeloid leukemia","volume":"24","author":"Zheng","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtct.2024.08.011_bib0034","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41375-023-02075-9","article-title":"High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia","volume":"38","author":"Tomizawa","year":"2024","journal-title":"Leukemia"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724006043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724006043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T01:52:27Z","timestamp":1762048347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636724006043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2666636724006043"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2024.08.011","relation":{},"ISSN":["2666-6367"],"issn-type":[{"type":"print","value":"2666-6367"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Retrospective Study of Pediatric Patients With Low- or Intermediate-Risk Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation for the AML-05 Study Conducted by the Japanese Pediatric Leukemia\/Lymphoma Study Group","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2024.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}